CrossBridge Bio
United States
- Houston, Texas
- 05/11/2024
- Unknown
- $10,000,000
CrossBridge Bio is a biotechnology company focused on developing innovative ADC therapeutics using our proprietary stable dual-linker payload technology.
- Industry Biotechnology Research
- Website https://crossbridgebio.com/
- LinkedIn https://www.linkedin.com/company/crossbridge-bio/
Related People
Michael TorresFounder
United States -
Houston, Texas
I have a passion for translating science into medicines. I believe the best mechanism to get new and innovative drugs to patients is through biopharma. To that end, I am a scientist entrepreneur and have successfully taken a project I initiated into a fully-formed venture backed biotech company.
I have a background in equity research and familiarity with sell-side, buy-side analysis. This, coupled with my hands on the bench have driven my passion of turning ideas into companies. I now have experience recruiting talented scientists to co-develop new IP, incorporating, licensing said technology, and raising funds while managing the day to day operations of a startup. While these experiences are important for my personal career, the chance to bring new medicines to underserved patient populations is core to my drive.
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)